| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/14/2010 | US20100009992 Ampk modulators |
| 01/14/2010 | US20100009989 Urea Glucokinase Activators |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009982 Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof |
| 01/14/2010 | US20100009947 2-Methylene-19,26-Dinor-(20S,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009946 2-Methylene-19,26-Dinor-(20R,22E,25R)-Vitamin D Analogs |
| 01/14/2010 | US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis |
| 01/14/2010 | US20100009943 2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009940 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009932 Liquid Satiety Enhancing Composition |
| 01/14/2010 | US20100009923 Antigens Targeted by Pathogenic Al4 T Cells in Type 1 Diabetes and Uses Thereof |
| 01/14/2010 | US20100009919 Apolipoprotein A1 Mimetics and Uses Thereof |
| 01/14/2010 | US20100009916 Selective vpac2 receptor peptide agonists |
| 01/14/2010 | US20100009910 Methods for administering long-lasting hypoglycemic agents |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009904 Modified Exedins and Uses Thereof |
| 01/14/2010 | US20100009900 2-{3-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-1H-indol-4-yloxy} beta -D-glucopyranoside; sodium glucose transporter inhibitor; antidiabetic agent; Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, hypertension, ischemia, stroke, heart disease, irritable bowel disorder, cataracts |
| 01/14/2010 | US20100009015 Use of chromium histidinate for treatment of cardiometabolic disorders |
| 01/14/2010 | US20100009014 Use of composition for manufacture of medicant and method for inhibiting formation of body fat |
| 01/14/2010 | US20100008933 Methods For Treating Obesity By Administering A TRKB Antagonist |
| 01/14/2010 | US20100008929 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 01/14/2010 | US20100008924 Fusion proteins and their use in the diagnosis and treatment of leishmaniasis |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008899 Methods of diagnosis and treatment for metabolic disorders |
| 01/14/2010 | US20100008887 Anti-obesity composition containing acacia bark derivative |
| 01/14/2010 | CA2730511A1 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 01/14/2010 | CA2730258A1 Mineral amino acid polysaccharide complex |
| 01/14/2010 | CA2730257A1 2-methylene-19,26-dinor-(20s,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730254A1 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | CA2730248A1 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730247A1 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730244A1 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730078A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/14/2010 | CA2730065A1 Improving renal function with quercetin-containing compositions |
| 01/14/2010 | CA2729767A1 Novel compounds, pharmaceutical compositions containing same, methods of use for same, and methods for preparing same |
| 01/14/2010 | CA2729619A1 Nutritive compositions and methods of using same |
| 01/14/2010 | CA2728042A1 Piperidinyl gpcr agonists |
| 01/14/2010 | CA2670964A1 Use of composition for manufacture of medicant and method for inhibiting formation of body fat |
| 01/13/2010 | EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 01/13/2010 | EP2143443A1 Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener |
| 01/13/2010 | EP2143434A1 Composition for promoting ketone compound formation |
| 01/13/2010 | EP2143427A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/13/2010 | EP2143424A1 Oral pharmaceutical preparation for colon-specific delivery |
| 01/13/2010 | EP2142552A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/13/2010 | EP2142551A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
| 01/13/2010 | EP2142521A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/13/2010 | EP2142519A1 Dpp-iv inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity |
| 01/13/2010 | EP2142256A1 Treatment of obesity |
| 01/13/2010 | EP2142204A1 Novel use of cocoa extract |
| 01/13/2010 | EP2142201A1 Use of cocoa extract |
| 01/13/2010 | EP2142184A1 Use of s1p receptor modulator |
| 01/13/2010 | EP2021337B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/13/2010 | EP1406910B1 Preparation methods of derivatives of bisphosphonates |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | EP0969838B2 Controlled release compositions for the treatment of hyperlipidemia |
| 01/13/2010 | CN100579606C Use of whey permeate for the treatment of metabolic syndrome |
| 01/13/2010 | CN100579575C Polypeptide protein class-medicament under-tongue instant nanometer emulsion and 3D printing preparing method thereof |
| 01/13/2010 | CN100579567C Use of Chinese medicine preparation in preparing medicine for defending coronary heart disease |
| 01/13/2010 | CN100579550C Medicinal composition for reducing blood lipid and reducing weight and preparation process thereof |
| 01/13/2010 | CN100579543C Chinese medicine for treating diabetes |
| 01/13/2010 | CN100579529C Alprostadil freeze-dried emulsion and its preparation method |
| 01/13/2010 | CN100579524C Method of preparing simvastatin sustained-release microsphere carried series |
| 01/13/2010 | CN100579520C Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 01/13/2010 | CN100579395C Instant nutritive gruel having a function of stabilizing body blood sugar after meal and method for preparing the same |
| 01/13/2010 | CN100579394C Rice conjee for treating diabetes |
| 01/13/2010 | CN100579393C Poria-cocos eight-treasures noodles and preparing method |
| 01/13/2010 | CN100579386C Amber aroma health-care tea |
| 01/12/2010 | US7645791 5-tert-Butyl-4-hydroxy-2-methyl-biphenyl-3-carboxylic acid (2-chloro-4-nitro-phenyl) -amide; chemical uncouplers like for the treatment of obesity |
| 01/12/2010 | US7645787 4'-((2-fluoro-4-methylphenyl)methyl)-1'-isopropyl-5'-methyl-1H-pyrazole-3'-O-(6-carbomethoxy)- beta -D-glucopyranoside; 4-[(3-fluoro-4-methoxyphenyl)methyl]-1-isopropyl-5-methyl-1H-pyrazole-3-O- beta -D-glucopyranoside; reducing reanal glucose reabsorption |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645774 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | US7645763 dipeptidylpeptidase-IV inhibitors; antidiabetic agents, antiarthritic agents, obesity, allograft transplantation, and osteoporosis caused by calcitonin; 1,3-disubstituted-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)-xanthine compounds |
| 01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/12/2010 | US7645756 Nitrogenous fused heteroaromatic ring derivative |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | CA2461946C Combinations for the treatment of immunoinflammatory disorders |
| 01/12/2010 | CA2373936C Nasogastric enteral formulations |
| 01/12/2010 | CA2373281C Methods of treating diabetes using a complex of igf-1 and igfbp-3 |
| 01/12/2010 | CA2276373C Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 01/12/2010 | CA2254954C Morphogen treatment for chronic renal failure |
| 01/07/2010 | WO2010002010A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | WO2010001990A1 Tetracyclic compound |
| 01/07/2010 | WO2010001946A1 Triazole derivative or salt thereof |
| 01/07/2010 | WO2010001933A1 Histone modification inhibitor specific to target gene |
| 01/07/2010 | WO2010001932A1 Pharmaceutical composition containing surface-coated microparticles |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010001166A1 Thiazole derivatives as gpr 119 modulators |
| 01/07/2010 | WO2010000978A1 Novel pyrrolo [2,3-a] carbazoles and use thereof as pim kinase inhibitors |
| 01/07/2010 | WO2010000656A1 Rna antagonist compounds for the inhibition of expression of mitochondrial glycerol-3-phosphate acyltransferase 1 (mtgpat1) |
| 01/07/2010 | WO2010000456A1 Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
| 01/07/2010 | WO2010000401A1 Use of substituted pyridinone carboxylic acid derivates for producing pharmaceuticals for the treatment of dyslipidemia |
| 01/07/2010 | WO2010000353A1 Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| 01/07/2010 | WO2009131740A3 Neutralizing proprotein convertase subtilisin kexin type 9 (pcsk9) variants and uses thereof |
| 01/07/2010 | WO2009112691A3 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof |
| 01/07/2010 | US20100004470 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 01/07/2010 | US20100004327 Novel Use of Ansamycin Antibiotics And Method of Screening Novel Angiogenesis Inhibitor |
| 01/07/2010 | US20100004312 Fused cyclic compounds |
| 01/07/2010 | US20100004309 Dietary Compositions and Methods for Protection Against Chemotherapy, Radiotherapy, Oxidative Stress, and Aging |